Seroatlas · Human Serome Atlas

CECR9

Putative cat eye syndrome critical region protein 9

Also known as: CECR9_HUMAN

Cross-references: UniProt · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession: P0C854
Gene: CECR9
Canonical length: 216 aa

OverviewNCBI Gene

No narrative summary is available for CECR9 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

216 residues, UniProt reviewed canonical sequence.

>P0C854|CECR9
     1  MQSHLAPLAC AAAAGRAGGS CQAAQPEDRR VLRYPGTAVM VTCPNRPLVP RPLLTPGGSR
    61  ASLALCAFVA VPQRIPQPLL PAYILLMLPS LVVDMALPSS RLLRSIKPIQ PASQVVRKER
   121  NPNPNCPQSD PLMKASSTSF LSHTYLINKT RSTTRKVEEH SWFTCTGAKY FAIPLAERNT
   181  KRLTKRSTHA QLLRGKQDGS EWVVPRSSAS SNVLYH

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CECR9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability: Secreted
Secreted: Yes
Transmembrane segments: 0
Mean surface accessibility (rSASA): 0.69

OntologyGO

Cellular components

extracellular region

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CECR9 as an antibody target. Whether an autoantibody or antibody against CECR9 could matter depends on whether native CECR9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CECR9 is annotated as secreted, so native CECR9 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label CECR9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Loading the interactive Seroatlas protein explorer...